Literature DB >> 15501768

Cytokine response to infection with Bacillus anthracis spores.

Alison K Pickering1, Manuel Osorio, Gloria M Lee, Vanessa K Grippe, Mechelle Bray, Tod J Merkel.   

Abstract

Bacillus anthracis, the etiological agent of anthrax, is a gram-positive, spore-forming bacterium. The inhalational form of anthrax is the most severe and is associated with rapid progression of the disease and the outcome is frequently fatal. Transfer from the respiratory epithelium to regional lymph nodes appears to be an essential early step in the establishment of infection. This transfer is believed to occur by means of carriage within alveolar macrophages following phagocytosis. Therefore, the ability of B. anthracis to transit through the host macrophage or dendritic cell appears to be an early and critical step in B. anthracis pathogenesis. In this work, we examined the cytokine responses to spore infection in mouse primary peritoneal macrophages, in primary human dendritic cells, and during a spore aerosol infection model utilizing the susceptible A/J mouse strain. We demonstrated that both mouse peritoneal macrophages and human dendritic cells exhibited significant intracellular bactericidal activity during the first hours following uptake, providing the necessary time to mount a cytokine response prior to cell lysis. Strong tumor necrosis factor (TNF-alpha) and interleukin-6 (IL-6) responses were seen in mouse peritoneal macrophages. In addition to TNF-alpha and IL-6, human dendritic cells produced the cytokines IL-1beta, IL-8, and IL-12. A mixture of Th1 and Th2 cytokines were detected in sera obtained from infected animals. In this study, we provide further evidence of an acute cytokine response when cells in culture and mice are infected with B. anthracis spores.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501768      PMCID: PMC523056          DOI: 10.1128/IAI.72.11.6382-6389.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Differences in susceptibility of inbred mice to Bacillus anthracis.

Authors:  S L Welkos; T J Keener; P H Gibbs
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  Early Bacillus anthracis-macrophage interactions: intracellular survival survival and escape.

Authors:  T C Dixon; A A Fadl; T M Koehler; J A Swanson; P C Hanna
Journal:  Cell Microbiol       Date:  2000-12       Impact factor: 3.715

3.  Cytological features of anthrax spores phagocytized in vitro by rabbit alveolar macrophages.

Authors:  F Shafa; B J Moberly; P Gerhardt
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

4.  Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha.

Authors:  R Pellizzari; C Guidi-Rontani; G Vitale; M Mock; C Montecucco
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

5.  Woolsorters' disease. An experimental model.

Authors:  F G Dalldorf; A F Kaufmann; P S Brachman
Journal:  Arch Pathol       Date:  1971-12

6.  Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice.

Authors:  S L Welkos; R W Trotter; D M Becker; G O Nelson
Journal:  Microb Pathog       Date:  1989-07       Impact factor: 3.738

7.  Postexposure prophylaxis against experimental inhalation anthrax.

Authors:  A M Friedlander; S L Welkos; M L Pitt; J W Ezzell; P L Worsham; K J Rose; B E Ivins; J R Lowe; G B Howe; P Mikesell
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

8.  On the role of macrophages in anthrax.

Authors:  P C Hanna; D Acosta; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin.

Authors:  J L Erwin; L M DaSilva; S Bavari; S F Little; A M Friedlander; T C Chanh
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

10.  Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.

Authors:  S L Welkos; A M Friedlander
Journal:  Microb Pathog       Date:  1988-01       Impact factor: 3.738

View more
  47 in total

1.  Campylobacter jejuni induces maturation and cytokine production in human dendritic cells.

Authors:  Lan Hu; Mechelle D Bray; Manuel Osorio; Dennis J Kopecko
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.

Authors:  Christopher K Cote; Nico Van Rooijen; Susan L Welkos
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection.

Authors:  Steven M Opal; Yow-Pin Lim; Patricia Cristofaro; Andrew W Artenstein; Noubar Kessimian; David Delsesto; Nicolas Parejo; John E Palardy; Edward Siryaporn
Journal:  Shock       Date:  2011-01       Impact factor: 3.454

5.  Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.

Authors:  Manuel Osorio; Yanping Wu; Sunil Singh; Tod J Merkel; Siba Bhattacharyya; Milan S Blake; Dennis J Kopecko
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

6.  Comprehensive Laboratory Evaluation of a Highly Specific Lateral Flow Assay for the Presumptive Identification of Bacillus anthracis Spores in Suspicious White Powders and Environmental Samples.

Authors:  Jason G Ramage; Kristin W Prentice; Lindsay DePalma; Kodumudi S Venkateswaran; Sruti Chivukula; Carol Chapman; Melissa Bell; Shomik Datta; Ajay Singh; Alex Hoffmaster; Jawad Sarwar; Nishanth Parameswaran; Mrinmayi Joshi; Nagarajan Thirunavkkarasu; Viswanathan Krishnan; Stephen Morse; Julie R Avila; Shashi Sharma; Peter L Estacio; Larry Stanker; David R Hodge; Segaran P Pillai
Journal:  Health Secur       Date:  2016 Sep-Oct

7.  Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.

Authors:  Crystal L Loving; Taruna Khurana; Manuel Osorio; Gloria M Lee; Vanessa K Kelly; Scott Stibitz; Tod J Merkel
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

8.  Transcriptional profiling of Bacillus anthracis during infection of host macrophages.

Authors:  Nicholas H Bergman; Erica C Anderson; Ellen E Swenson; Brian K Janes; Nathan Fisher; Matthew M Niemeyer; Amy D Miyoshi; Philip C Hanna
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

9.  Nod1/Nod2-mediated recognition plays a critical role in induction of adaptive immunity to anthrax after aerosol exposure.

Authors:  Crystal L Loving; Manuel Osorio; Yun-Gi Kim; Gabriel Nuñez; Molly A Hughes; Tod J Merkel
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

10.  Inhalation anthrax: dose response and risk analysis.

Authors:  Margaret E Coleman; Brandolyn Thran; Stephen S Morse; Martin Hugh-Jones; Stacey Massulik
Journal:  Biosecur Bioterror       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.